Non-cirrhotic Portal Hypertension as the Initial Presentation of Limited Cutaneous Scleroderma: A Case Report
- PMID: 37132021
- PMCID: PMC10161292
- DOI: 10.1177/23247096231171251
Non-cirrhotic Portal Hypertension as the Initial Presentation of Limited Cutaneous Scleroderma: A Case Report
Abstract
Systemic sclerosis (SSc) is an autoimmune disease characterized by progressive skin fibrosis. It has 2 main clinical subtypes-diffuse cutaneous scleroderma and limited cutaneous scleroderma. Non-cirrhotic portal hypertension (NCPH) is defined as presence of elevated portal vein pressures without cirrhosis. It is often a manifestation of an underlying systemic disease. On histopathology, NCPH may be found to be secondary to multiple abnormalities such as nodular regenerative hyperplasia (NRH) and obliterative portal venopathy. There have been reports of NCPH in patients with both subtypes of SSc secondary to NRH. However, simultaneous presence of obliterative portal venopathy has not been reported. We present a case of NCPH due to NRH and obliterative portal venopathy as a presenting sign of limited cutaneous scleroderma. The patient was initially found to have pancytopenia and splenomegaly and was erroneously labeled as cirrhosis. She underwent workup to rule out leukemia, which was negative. She was referred to our clinic and diagnosed with NCPH. Due to pancytopenia, she could not be started on immunosuppressive therapy for her SSc. Our case describes the presence of these unique pathological findings in the liver and highlights the importance of an aggressive search for an underlying condition in all patients diagnosed with NCPH.
Keywords: Raynaud phenomenon; elastography; idiopathic non-cirrhotic portal hypertension; systemic sclerosis.
Conflict of interest statement
The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Figures


Similar articles
-
A case of idiopathic portal hypertension accompanying multiple hepatic nodular regenerative hyperplasia in a patient with systemic sclerosis.Clin J Gastroenterol. 2021 Jun;14(3):820-826. doi: 10.1007/s12328-021-01348-z. Epub 2021 Apr 22. Clin J Gastroenterol. 2021. PMID: 33886104
-
Liver transplantation in precirrhotic biliary tract disease: Portal hypertension is frequently associated with nodular regenerative hyperplasia and obliterative portal venopathy.Am J Surg Pathol. 2006 Nov;30(11):1454-61. doi: 10.1097/01.pas.0000213286.65907.ea. Am J Surg Pathol. 2006. PMID: 17063088
-
Obliterative portal venopathy without portal hypertension: an underestimated condition.Liver Int. 2016 Mar;36(3):454-60. doi: 10.1111/liv.12936. Epub 2015 Sep 6. Liver Int. 2016. PMID: 26264219
-
Non-cirrhotic portal hypertension - diagnosis and management.J Hepatol. 2014 Feb;60(2):421-41. doi: 10.1016/j.jhep.2013.08.013. Epub 2013 Aug 23. J Hepatol. 2014. PMID: 23978714 Review.
-
Living donor liver transplantation for idiopathic portal hypertension with extrahepatic portal vein stenosis and splenic artery aneurysms: a case report and review of the literature.BMC Surg. 2020 Oct 29;20(1):257. doi: 10.1186/s12893-020-00921-6. BMC Surg. 2020. PMID: 33121468 Free PMC article. Review.
Cited by
-
Non-cirrhotic Idiopathic portal hypertension in systemic sclerosis patients: report of one case and a systematic review of previous case reports.Adv Rheumatol. 2025 Mar 4;65(1):10. doi: 10.1186/s42358-025-00442-x. Adv Rheumatol. 2025. PMID: 40038804
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical